Meir Medical Center, Department of Obstetrics and Gynecology, Affiliated with the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
School of Medicine, New York State/American Program of Tel Aviv University, Tel Aviv, Israel.
PLoS One. 2024 Oct 4;19(10):e0301074. doi: 10.1371/journal.pone.0301074. eCollection 2024.
To evaluate pain perception and analgesic use between patients who underwent endometriosis-specific laparoscopic surgery compared to laparoscopic hysterectomy.
This retrospective cohort study included women diagnosed with endometriosis who underwent laparoscopic surgery from 1/2019 to 11/2022. The control group consisted of premenopausal women who underwent laparoscopic hysterectomy, which was considered a similarly extensive surgery. Demographics, preoperative and post-operative data were compared between groups. Post-operative pain scores on a visual analogue scale (VAS) between 0 (no pain) and 10 (worst pain) were compared between groups for each post-operative day (POD). Standard pain relief analgesia on POD 0-1 included fixed intravenous treatment with paracetamol and intramuscular diclofenac. The need for additional analgesics (morphine or dipyrone) beyond the standard pain relief protocol was compared between groups.
Among 200 patients who underwent laparoscopic surgery, 100 (50%) were in the endometriosis group and 100 (50%) in the hysterectomy group. The endometriosis group was characterized by younger age and lower parity (both, p<0.001). There was no significant difference between the groups in mean VAS scores for each post-operative day. However, among patients who needed additional analgesics beyond the standard protocol on POD 1, a higher percentage of women in the endometriosis group used opioids rather than milder analgesics, as compared to controls (1% vs. 0.2%, respectively, p = 0.03).
Increased post-operative morphine use was observed in patients with endometriosis following laparoscopic surgery, despite no significant difference in mean VAS scores during the post-operative days. These findings suggest that personalized pain relief protocols should be adjusted for women with endometriosis.
评估接受子宫内膜异位症特定腹腔镜手术与腹腔镜子宫切除术的患者之间的疼痛感知和镇痛药物使用情况。
这是一项回顾性队列研究,纳入了 2019 年 1 月至 2022 年 11 月期间接受腹腔镜手术的子宫内膜异位症患者。对照组为接受腹腔镜子宫切除术的绝经前妇女,该手术被认为是一种同样广泛的手术。比较两组间的人口统计学、术前和术后数据。比较两组间术后每天(POD)的视觉模拟评分(VAS)在 0(无痛)至 10(最痛)之间的术后疼痛评分。POD 0-1 时的标准止痛镇痛包括固定的静脉注射扑热息痛和肌肉注射双氯芬酸。比较两组间超出标准止痛方案需要额外镇痛药物(吗啡或安乃近)的情况。
在 200 例接受腹腔镜手术的患者中,100 例(50%)为子宫内膜异位症组,100 例(50%)为子宫切除术组。子宫内膜异位症组的特点是年龄较小和生育次数较低(均 p<0.001)。两组患者在每个术后日的平均 VAS 评分之间无显著差异。然而,在 POD 1 需要超出标准方案的额外镇痛药物的患者中,与对照组相比,子宫内膜异位症组中有更高比例的女性使用阿片类药物而不是较温和的镇痛药物(分别为 1%和 0.2%,p = 0.03)。
尽管在术后日期间的平均 VAS 评分无显著差异,但在接受腹腔镜手术后的子宫内膜异位症患者中观察到术后吗啡使用增加。这些发现表明,对于子宫内膜异位症患者,应调整个性化的止痛缓解方案。